483 Hisun Pharmaceutical Hangzhou Oct 2016

483 Hisun Pharmaceutical Hangzhou Oct 2016

Justin Boyd FDA, Sandra Hughes FDA$119.00 - Available Now

FDA investigators audited the Hisun Pharmaceutical Hangzhou - Hangzhou, China facility and issued inspectional observation (via FDA 483) on 27 Oct 2016.

Product details

  • Category: Human Drugs / Animal Drugs & Feeds
  • Inspection end: 27 Oct 2016
  • Location: Hangzhou, China
  • FEI: 3008481334
Add To Cart